Literature DB >> 6165794

Function of hepatic triglyceride lipase in lipoprotein metabolism.

J Grosser, O Schrecker, H Greten.   

Abstract

Rat hepatic triglyceride lipase (H-TGL) was purified from liver tissue extracts by affinity chromatography on Sepharose 4B with covalently linked heparin. The purified rat H-TGL exhibited the properties previously described for this enzyme. Enzyme protein was injected into rabbits for anti-H-TGL antibody production. Antirat-H-TGL did not react against rat lipoprotein lipase (LPL) but inhibited H-TGL-activity both in vitro and in vivo greater than 90%. These antibodies were injected into rats and lipoprotein analyses were performed over a 36-hr period. It could be shown that inactivation of H-TGL by anti-H-TGL gamma-globulins in vivo led to an increase in total triglyceride concentration from 70 mg/dl to 230 mg/dl due to an increase in very low density lipoprotein (VLDL) and low density lipoprotein (LDL) triglycerides 4 hr after antibody injection; a marked increase in high density lipoprotein (HDL) phospholipid concentration was observed with almost no change in HDL-cholesterol and HDL-triglycerides. This study documents the ability of antirat-H-TGL-gamma-globulins to inhibit H-TGL in vitro and in vivo. Furthermore, the inhibition of triglyceride removal in vivo demonstrated that this enzyme together with LPL is responsible for the catabolism of VLDL-triglyceride.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165794

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

1.  The preferential uptake of very-low-density lipoprotein cholesteryl ester by rat liver in vivo.

Authors:  J C Holder; V A Zammit; D S Robinson
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.

Authors:  J C Cohen; Z Wang; S M Grundy; M R Stoesz; R Guerra
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

Review 3.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

4.  Weight set-point theory and the high-density lipoprotein concentrations of long-distance runners.

Authors:  P T Williams
Journal:  Metabolism       Date:  1990-05       Impact factor: 8.694

5.  Lipoprotein lipase and hepatic lipase activities in a hypercholesterolaemic (RICO) strain of rat. Effect of dietary cholesterol.

Authors:  F Sultan; L E Cardona-Sanclemente; D Lagrange; C Lutton; S Griglio
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

6.  Evidence that cholesteryl ester hydrolase and triglyceride lipase are different enzymes in rat liver.

Authors:  J J Chen; V Rothman; S Margolis
Journal:  Lipids       Date:  1986-08       Impact factor: 1.880

7.  Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.

Authors:  A Rubinstein; J C Gibson; J R Paterniti; G Kakis; A Little; H N Ginsberg; W V Brown
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Association of plasma lipoproteins with postheparin lipase activities.

Authors:  I J Goldberg; J J Kandel; C B Blum; H N Ginsberg
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Influence of lysophosphatidylcholine on the C-apolipoprotein content of rat and human triglyceride-rich lipoproteins during triglyceride hydrolysis.

Authors:  E E Windler; S Preyer; H Greten
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 10.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.